Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $4.75 Million - $6.73 Million
-18,582 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $7.62 Million - $9.73 Million
-21,688 Reduced 53.86%
18,582 $7 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $8.75 Million - $10.8 Million
-23,474 Reduced 36.83%
40,270 $16.6 Million
Q2 2021

Aug 16, 2021

SELL
$294.17 - $371.65 $4.68 Million - $5.91 Million
-15,914 Reduced 19.98%
63,744 $23.6 Million
Q1 2021

May 14, 2021

SELL
$249.67 - $299.48 $24.8 Million - $29.8 Million
-99,496 Reduced 55.54%
79,658 $23.1 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $37.5 Million - $42.7 Million
-168,949 Reduced 48.53%
179,154 $44.8 Million
Q3 2020

Nov 12, 2020

SELL
$175.56 - $226.45 $11.4 Million - $14.7 Million
-64,823 Reduced 15.7%
348,103 $78.8 Million
Q2 2020

Aug 14, 2020

SELL
$118.84 - $189.72 $5.65 Million - $9.02 Million
-47,542 Reduced 10.32%
412,926 $72 Million
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $87,229 - $157,295
882 Added 0.19%
460,468 $58.1 Million
Q4 2019

Feb 14, 2020

BUY
$126.05 - $152.76 $2.84 Million - $3.44 Million
22,500 Added 5.15%
459,586 $70.2 Million
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $6.8 Million - $7.81 Million
54,340 Added 14.2%
437,086 $57.9 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $9.59 Million - $11.5 Million
77,700 Added 25.47%
382,746 $54.3 Million
Q1 2019

May 13, 2019

BUY
$104.82 - $146.73 $32 Million - $44.8 Million
305,046 New
305,046 $0

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Sculptor Capital LP Portfolio

Follow Sculptor Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Sculptor Capital LP with notifications on news.